S3 show the results for the outcome MACE: both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk for MACE (13% and 11%, respectively) as compared with placebo, and a lower risk for MACE as compared with DPP-4 inhibitors (12% and 11%, respectively)
Are there special considerations for vitamin B12 dosing in pregnancy
When levels fall, common signs include profound fatigue, lightheadedness, numbness, cognitive fog, and anemia
Drug Development & Approval Process
We utilize the most appropriate and scientifically advanced analytical techniques, along with a well-designed quality control system, to develop the finest-quality supplements
PubMed ID: 11673763 Mor MI et al